Belpointe Asset Management’s CapForce IBD 50 ETF FFTY Stock Holding History

Belpointe Asset Management’s Portfolio FFTY Stock Details FFTY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-10,021	Closed	-$277K	–	879
2024 Q1	$277K	Buy	+10,021	New	+$262K	0.02%	622

Other funds holding FFTY

IPW

IronBridge Private Wealth Austin, Texas $310M AUM 41.13% 1-Year Est. Return

DSCM

Del-Sette Capital Management Schenectady, New York $167M AUM 38.06% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

CPIG

Chicago Partners Investment Group Chicago, Illinois $4.48B AUM 19.29% 1-Year Est. Return

GVAG

Great Valley Advisor Group Wilmington, Delaware $5.5B AUM 20.56% 1-Year Est. Return

IWM

IHT Wealth Management Chicago, Illinois $4.3B AUM 21.02% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Belpointe Asset Management's FFTY Position: Q2 2024 in Review

Belpointe Asset Management sold out of CapForce IBD 50 ETF (FFTY) in Q2 2024, closing a stake of 10,021 shares — an estimated $277K sold.

Belpointe Asset Management first reported a position in FFTY in Q1 2024 and held it in 1 quarter. The position peaked at $277K in Q1 2024. 36 funds tracked by Wall St. Rank hold FFTY as of Q2 2024.

Belpointe Asset Management reported no remaining CapForce IBD 50 ETF position as of Q2 2024 after selling out during the quarter.
Belpointe Asset Management sold 10,021 CapForce IBD 50 ETF shares in Q2 2024, an estimated $277K.
Belpointe Asset Management first reported a position in CapForce IBD 50 ETF in Q1 2024 and held it in 1 quarter.
Belpointe Asset Management's CapForce IBD 50 ETF position peaked at $277K in Q1 2024.
36 funds tracked by Wall St. Rank held CapForce IBD 50 ETF as of Q2 2024.

Based on Belpointe Asset Management's 13F filing for Q2 2024, filed 2 Aug 2024.